glutathione mutations in sclc patients Role of the Metabolic Pathway Lung Cancer Treatment and Prognosis: A Review Oncology Letters
Oncology Letters Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications The flavonoid GL V9 induces oxidative stress mediated apoptosis in small cell lung cancer by promoting STEAP3 degradation ScienceDirect Tumor suppressor genes and KRAS G12C inhibitor resistance in non small cell lung cancer: iScience Frontiers Absence of Biomarker Driven Treatment Options in Small Cell Lung Cancer, and Selected Preclinical Candidates for Next Generation Combination Therapies Small cells big issues: biological implications and preclinical advancements in small cell lung cancer Molecular Cancer Springer Nature Link
Pay in 4 interest-free payments of $5.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





